NO and angiogenesis (Q35603936)

9 August 2017

1 reference

title

NO and angiogenesis (English)

1 reference

9 August 2017

1 reference

John P Cooke

1

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Atherosclerosis. Supplements

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

53-60

1 reference

Angiogenesis in cancer and other diseases

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nitric Oxide Inhibits Caspase-3 byS-Nitrosationin Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Podokinesis in endothelial cell migration: role of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nitric oxide synthase: role in the genesis of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Inhibitory effects of hypercholesterolemia and ox-LDL on angiogenesis-like endothelial growth in rabbit aortic explants. Essential role of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Hypercholesterolemia increases endothelial superoxide anion production

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Characterization and applications of the disc angiogenesis system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Limb blood flow during exercise is dependent on nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Occurrence of a new enzyme catalyzing the direct conversion of NG,NG-dimethyl-L-arginine to L-citrulline in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Double-edged role of statins in angiogenesis signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Endothelium-dependent effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Statins have biphasic effects on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Inhibition of monocyte chemotactic protein-1 synthesis by statins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Bacterial toxins block endothelial wound repair. Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

Vascular endothelial growth factor enhances atherosclerotic plaque progression

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900034-5

7 January 2021

10.1016/S1567-5688(03)00034-5

Identifiers

DOI

1 reference

9 August 2017

1 reference